- Patent Title: Genetically engineered hematopoietic stem cells and uses thereof
-
Application No.: US17222812Application Date: 2021-04-05
-
Publication No.: US11571445B2Publication Date: 2023-02-07
- Inventor: Joseph Bolen , Aleksandar Filip Radovic-Moreno , John Lydeard
- Applicant: VOR BIOPHARMA INC.
- Applicant Address: US MA Cambridge
- Assignee: VOR BIOPHARMA INC.
- Current Assignee: VOR BIOPHARMA INC.
- Current Assignee Address: US MA Cambridge
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K35/28
- IPC: A61K35/28 ; C12N15/00 ; A61P35/02 ; A61K35/17 ; A61K38/17 ; A61K39/395 ; C12N5/0789 ; C12N9/22 ; C12N15/11 ; C12N15/90 ; C07K14/705 ; A61P35/00 ; A61K35/12 ; A61K39/00
Abstract:
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Public/Granted literature
- US20210228641A1 GENETICALLY ENGINEERED HEMATOPOIETIC STEM CELLS AND USES THEREOF Public/Granted day:2021-07-29
Information query
IPC分类:
